Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Research Facilities Construction Grant (C06)
Project #
1C06RR014469-01
Application #
6033399
Study Section
Scientific and Technical Review Board on Biomedical and Behavioral Research Facilities (STRB)
Program Officer
Mccullough, Willie
Project Start
2000-07-01
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2002-06-30
Support Year
1
Fiscal Year
2000
Total Cost
$1,000,000
Indirect Cost
Name
Howard University
Department
Type
Schools of Pharmacy
DUNS #
056282296
City
Washington
State
DC
Country
United States
Zip Code
20059
Ogunwuyi, Oluwaseun; Kumari, Namita; Smith, Kahli A et al. (2016) Antiretroviral Drugs-Loaded Nanoparticles Fabricated by Dispersion Polymerization with Potential for HIV/AIDS Treatment. Infect Dis (Auckl) 9:21-32
Akala, Emmanuel O; Adesina, Simeon; Ogunwuyi, Oluwaseun (2016) Computer Optimization of Biodegradable Nanoparticles Fabricated by Dispersion Polymerization. Int J Environ Res Public Health 13:ijerph13010047
Ogunwuyi, O; Adesina, S; Akala, E O (2015) D-Optimal mixture experimental design for stealth biodegradable crosslinked docetaxel-loaded poly-?-caprolactone nanoparticles manufactured by dispersion polymerization. Pharmazie 70:165-76
Adesina, Simeon K; Holly, Alesia; Kramer-Marek, Gabriela et al. (2014) Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studies. J Pharm Sci 103:2546-55
Adesina, Simeon K; Wight, Scott A; Akala, Emmanuel O (2014) Optimization of the fabrication of novel stealth PLA-based nanoparticles by dispersion polymerization using D-optimal mixture design. Drug Dev Ind Pharm 40:1547-56
Bol'shakov, Oleg I; Akala, Emmanuel O (2014) MS-Monitored Conjugation of Poly(ethylene glycol) Monomethacrylate to RGD Peptides. J Appl Polym Sci Symp 131:
Edafiogho, Ivan O; Kombian, Samuel B; Ananthalakshmi, Kethireddy V V et al. (2007) Enaminones: Exploring additional therapeutic activities. J Pharm Sci 96:2509-31